Evidence map›Paper›PMID 24465156›Full record

Trial reportInternational journal of medical sciences2014

Effects of a pre-workout supplement on lean mass, muscular performance, subjective workout experience and biomarkers of safety.

A William Kedia, Jennifer E Hofheins, Scott M Habowski, Arny A Ferrando, M David Gothard, Hector L Lopez

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Safety of a dose-escalated pre-workout supplement in recreationally active females.Journal of the International Society of Sports Nutrition · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

A William Kedia1. The Center for Applied Health Sciences, 4302 Allen Road, Suite 120, Stow, OH 44224, USA.
Jennifer E Hofheins1. The Center for Applied Health Sciences, 4302 Allen Road, Suite 120, Stow, OH 44224, USA.
Scott M Habowski1. The Center for Applied Health Sciences, 4302 Allen Road, Suite 120, Stow, OH 44224, USA.
Arny A Ferrando2. Center for Translational Research in Aging and Longevity, University of Arkansas for Medical Sciences, 4305 W. Markham St Slot 806, Little Rock, AR 72205, USA.
M David Gothard3. BIOSTATS, 501 Wood Street North, East Canton, Ohio 44730, USA.
Hector L Lopez1. The Center for Applied Health Sciences, 4302 Allen Road, Suite 120, Stow, OH 44224, USA.
Allen Hospital · USBiostats (United States) · USUniversity of Arkansas for Medical Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this prospective, randomized, double-blind, trial conducted in two parts, we examined the effects of a multi-ingredient pre-exercise workout supplement blend of creatine, betaine and a dendrobium extract (MMP) on safety, performance, and body composition in healthy men and women undergoing a supervised program of resistance exercise. Part 1 was an acute hemodynamic safety study wherein forty young, healthy men and women (26.2 ± 5.3 years, 70.4 ± 3.3 inches, 83.7 ± 14.9 kg, 26.0 ± 3.2 kg●m(-2)) ingest one dose of either the MMP or comparator in a randomized, double-blind, comparator controlled, crossover fashion before having their resting heart rate, blood, ECG and comprehensive blood chemistry and blood counts completed. Systolic (SBP) and diastolic (DBP) blood pressures were generally raised (3.0-5.4 mm Hg, p<0.01) following supplementation with MPP whereas in the comparator group SBP was marginally reduced by 0.3 to 1.2 mm Hg, p>0.05 at all time points) and DBP was increased (3.0 - 3.9 mm Hg, p<0.05 at all time points). No changes in EKG-corrected QT interval were observed, and no serious adverse events were reported. Part 2 was a six-week training study wherein forty-three young, healthy men and women (24.3 ± 2.9 years, 70.5 ± 3.1 inches, 83.8 ± 9.6 kg, 26.1 ± 2.7 kg●m(-2)) supplemented with daily pre-workout doses of either the MPP or a comparator in a randomized, double-blind, comparator-controlled fashion while following a standardized resistance training program for six weeks. MPP and the comparator were isocaloric and delivered the same amount of caffeine. Significant improvements in visual analog scale (VAS) scores for energy (p<0.024) and concentration (p<0.041) were found along with consistently higher levels of focus accompanied by less fatigue when MPP was consumed in comparison to comparator during upper body muscular strength-endurance tests at weeks 3 and 6. MPP supplementation for 6 weeks did not improve dual-energy x-ray absorptiometry (DEXA) measures of body composition or objective assessments of exercise performance. Overall, MPP use and administration was well tolerated. Self-reported scores for energy and concentration were significantly greater. Over a six-week training and supplementation period, MPP use was not associated with improvements in performance or body composition. Future studies should confirm these effects over a more prolonged training period.

Indexed as

Dietary SupplementsExerciseAdipose TissueAdultBiomarkersBody CompositionBody Mass IndexCaffeineCreatineFemaleHumansMaleMiddle AgedMuscle, SkeletalMuscle StrengthBiomarkersCaffeineCreatinebotanicalscaffeinecreatinedendrobiumdietary supplementpre-workoutsafetysports nutrition

Identifiers

PMID24465156
PMCPMC3894395
OpenAlexW2096108404

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.